Research and Development Costs. Except where AstraZeneca is carrying out additional research and development activities to bring forward Nominated Compounds all other research and Development costs will be the responsibility of Flexion, including any activities which Flexion undertakes pre-acceptance in order to determine whether a Nominated Compound meets the Acceptance Criteria.
Appears in 2 contracts
Sources: Out Licence Agreement (Flexion Therapeutics Inc), Out Licence Agreement (Flexion Therapeutics Inc)